MUC1 and triple-negative breast carcinoma: (70) showed that the transmembrane mucin MUC1 contributed to immunologic escape in triple-negative breast cancer (TNBC) and that targeting MUC1-C correlated with PD-L1 suppression to activate the immune response and tumor cell killing.